Catalyst Wire Dossier Catalyst Wire Dossier

EFLA400 Korea Red Ginseng Extract

null · null
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EFLA400 Korea Red Ginseng Extract, covering 2019-09-23 to 2019-09-23. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of EFLA400 Korea Red Ginseng Extract on Sexual Function in Men With Erectile Dysfunction [NA]

See pricing